Maravai Lifesciences Holdings (MRVI) Deferred Taxes (2020 - 2024)

Maravai Lifesciences Holdings' Deferred Taxes history runs 5 years deep, the most recent figure standing at $11000.0 for Q4 2024.

• On a quarterly basis, Deferred Taxes fell 100.0% year-over-year to $11000.0 in Q4 2024; TTM through Dec 2024 was $11000.0, a 100.0% decrease from a year earlier, with the FY2025 full-year figure at -$20000.0, down 281.82% from the prior year.
• Deferred Taxes slipped to $11000.0 in Q4 2024 per MRVI's latest filing, from $764.8 million in the prior quarter.
• Across five years, Deferred Taxes topped out at $764.8 million in Q4 2023 and bottomed at -$5.5 million in Q3 2023.
• The 5-year median for Deferred Taxes is $6.7 million (2021), against an average of $52.4 million.
• Across the five-year window, Deferred Taxes jumped 1122800.0% in 2021 and tumbled 159.91% in 2023, its largest moves.
• Year by year, Deferred Taxes stood at -$4.2 million in 2020, then surged by 516.95% to $17.5 million in 2021, then slumped by 59.86% to $7.0 million in 2022, then soared by 10807.86% to $764.8 million in 2023, then slumped by 100.0% to $11000.0 in 2024.
• Per Business Quant, the three latest MRVI Deferred Taxes figures stand at $11000.0 (Q4 2024), $764.8 million (Q4 2023), and -$5.5 million (Q3 2023).